Filing Details

Accession Number:
0000886163-11-000011
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-02-18 17:38:42
Reporting Period:
2011-02-16
Filing Date:
2011-02-18
Accepted Time:
2011-02-18 17:38:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
886163 Ligand Pharmaceuticals Inc LGND Pharmaceutical Preparations (2834) 770160744
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1392266 S Charles Berkman 11085 North Torrey Pines Road, Suite 300
La Jolla CA 92037
Vp, Gen. Counsel & Secretary No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2011-02-16 5,000 $9.75 11,696 No 4 S Direct
Common Stock Acquisiton 2011-02-17 3,000 $0.00 14,696 No 4 A Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 A Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Incentive Stock Option (right to buy) Acquisiton 2011-02-17 10,221 $10.05 10,221 $10.05
Common Stock Non-Qualified Stock Option (right to buy) Acquisiton 2011-02-17 4,779 $10.05 4,779 $10.05
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
10,221 2021-02-17 No 4 A Direct
4,779 2021-02-17 No 4 A Direct
Footnotes
  1. Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Optioned Shares per month thereafter.